Inhibition by anandamide and synthetic cannabimimetics of the release of [ 3H]D-aspartate and [ 3H]GABA from synaptosomes isolated from the rat hippocampus

Neurochemical Research

Volumn 29, Issue 8, 2004, Pages 1553-1561

  D'Amico, M ^a   Cannizzaro, C ^b   Preziosi, P ^a   Martire, M ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cannabinoid; capsaicin; glutamatergic and GABAergic transmission; superfused hippocampal synaptosomes

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 AMINOBUTYRIC ACID; ANANDAMIDE; ARACHIDONYL 2' CHLOROETHYLAMIDE; ASPARTIC ACID; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; CAPSAZEPINE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; SYNAPTOSOME;

ANIMALS; ARACHIDONIC ACIDS; ASPARTIC ACID; CALCIUM; CANNABINOIDS; CAPSAICIN; CYCLOHEXANOLS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; KINETICS; MALE; POLYUNSATURATED ALKAMIDES; POTASSIUM; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; SYNAPTOSOMES;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 3042741201     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000029569.20266.3f     Document Type: Article

References (41)

1. Ameri, A. 1999. The effects of cannabinoids on the brain. Progr. Neurobiol. 58:315-348.
2. Iversen, L. 2003. Cannabis and the brain. Brain 126:1252-1270.
3. Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
4. Wilson, R. I. and Nicoll, R. A. 2002. Endocannabinoid signalling in the brain. Science 296:678-682.
5. Mechoulam, R., Ben-Shabat, S., Hanuš L., Ligumsky, M., Kaminski, N., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., Pertwee, R. G., Griffin, G., Bayewitch, M., Barg, J., and Vogel, Z. 1995. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50:83-90.
6. Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J. C., and Piomelli, D. 1994. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
7. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
8. Munro, S., Thomas, K. L., and Abu-Shaar, M. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65.
9. Howlett, A. C. 1995. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:607-634.
10. Parolaro, D. 1999. Presence and functional regulation of cannabinoid receptors in immune cells. Life Sci. 65:637-644.
11. Herkenham, M., Lynn, A. B., Johnson, M. R., Melvin, L. S., de Costa, B. R., and Rice, K. C. 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:563-583.
12. Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., and Walker, J. M. 1998. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat cental nervous system. Neuroscience 83:393-411.
13. Breivogel, C. S., Griffin, G., Di Marzo, V., and Martin, B. R. 2001. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 60:155-163.
14. Katona, I., Sperlágh, B., Sik, A., Köfalvi, A., Vizi, E. S., Mackie, K., and Freund, T. F. 1999. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19:4544-4558.
15. Hoffman, A. F. and Lupica, C. R. 2000. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J. Neurosci. 20:2470-2479.
16. Misner, D. L. and Sullivan, J. M. 1999. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 19:6795-6805.
17. Katona, I., Sperlágh, B., Maglóczky, Z., Sántha, E., Köfalvi, A., Czirják, S., Mackie, K., Vizi, E. S., and Freund, T. F. 2000. GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 100:797-804.
18. Hájos, N., Ledent, C., and Freund, T. F. 2001. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106:1-4.
19. 3H]D-Aspartate release in rat spinal cord synaptosomes: modulation by neuropeptide Y and calcium channel antagonists. J. Neurosci. Res. 62:722-729.
20. Raiteri, M., Sala, R., Fassio, A., Rossetto, O., and Bonanno, G. 2000. Entrapping of impermeant probes of different size into nonpermeabilized synaptosomes as a method to study presynaptic mechanisms. J. Neurochem. 74:423-131.
21. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
22. Raiteri, M., Angelini, F., and Levi, G. 1974. A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol. 25:411-114.
23. Hillard, C. J., Manna S., Grenberg, M. J., Dicamelli, R., Ross, R. A., Stevenson, E. A., Murphy, V., Pertwee, R. G., and Campbell, W. B. 1999. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Ther. 289:1427-1433.
24. Pertwee, R. G. 1999. Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem. 6:635-664.
25. Hescheler, J., Rosenthal, W., Trautwein, W., and Schultz, G. 1987. The GTP-binding protein. Go, regulates neuronal calcium channels. Nature 325:445-447.
26. Ong, W. Y. and Mackie, K. A. 1999. A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain. Neuroscience 92:1177-1191.
27. Davies, S. N., Pertwee, R. G., and Riedel, G. 2002. Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42:993-1007.
28. Tsou, K., Mackie, K., Sañudo-Peña, M. C., and Walker, J. M. 1999. Cannabinoid CB1 receptors are localized primarily on cholecystokinin- containing GABAergic interneurons in the rat hippocampal formation. Neuroscience 93:969-975.
29. Hájos, N., and Freund, T. F. 2002. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem. Phys. Lipids 121:73-82.
30. Shen, M., Piser, T. M., Seybold, V. S., and Thayer, S. A. 1996. Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J. Neurosci. 16:4322-1334.
31. Sullivan, J. M. 1999. Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. J. Neurophysiol. 82:1286-1294.
32. Levi, G., Banay-Schwartz, M., and Raiteri, M. 1981. Studies on the release of exogenous and endogenous GABA and glutamate from rat brain synaptosomes. Neurochem. Res. 6:275-284.
33. Stella, N., Schweitzer, P., and Piomelli, D. 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778.
34. Caterina, M. J., Schumacher, M. A., Tominga, M., Rosen, T. A., Levine, J. D., and Julius, D. 1997. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816-824.
35. 2+ entry in PC12 cells. J. Pharmacol. Exp. Ther. 291:107-114.
36. Pacheco, M., Childers, S. R., Arnold, R., Casiano, F., and Ward, S. J. 1991. Aminoalkylindoles: actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 257:170-183.
37. Wang, S-J. 2003. Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes. Eur. J. Pharmacol. 469:47-55.
38. 3H] glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur. J. Neurosci. 18:1973-1978.
39. Nicholson, R. A., Liao, C., Zheng, J., David, L. S., Coyne, L., Errington, A. C., Singh, G., and Lees, G. 2003. Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. Brain Res. 978:194-204.
40. Di Marzo, V., Breivogel, C. S., Tao, Q., Bridgen, D. T., Razdan, R. K., Zimmer, A. M., Zimmer, A., and Martin, B. R. 2000. Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 75:2434-2444.
41. Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., and Bonner, T. I. 1999. Increased mortality, hypoactivity and hypoalgesia in CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96:5780-5785.